Lalwani Nikhil 4
4 · ANI PHARMACEUTICALS INC · Filed Mar 14, 2025
Insider Transaction Report
Form 4
Lalwani Nikhil
DirectorPRESIDENT & CEO
Transactions
- Tax Payment
Common Stock
[F1]2025-03-07$60.62/sh−17,060$1,034,177→ 485,634 total
Footnotes (1)
- [F1]Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 33,352 shares of restricted stock, the grant of which was previously reported.
Signature
/s/ Nikhil Lalwani, by attorney-in-fact Meredith W. Cook|2025-03-14